Application Due Date: July 8, 2022
The purpose of this Funding Opportunity Announcement (FOA) is to support the development of new diagnostic technologies for tuberculosis (TB) drug susceptibility testing (DST), including point of care (POC) DST and companion diagnostics for new TB drugs.
Topics: Impact to Conduct of Research, Prognostics, Healthcare Implementation, Health Disparities, Diagnostics, Diagnostics Development, Diagnostic Efficacy, Diagnostic Scalability, Diagnostic Reliability, Treatments, Drug Development, Drug Repurposing, Drug Targets, Drugs, Treatment Efficacy, Treatment Reliability, Treatment Scalability